Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 6.30% is 53% above its 1-year average of 4.12%, around the middle of its 1-year range (0.00%–9.14%).
53.06% above its 12-month average of 4.12%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.14%.
NET PROFIT MARGIN
6.30%
NET PROFIT MARGIN AVG TTM
4.12%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+53.06%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$563178.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
Market Cap
$809925.00
Net Profit Margin
N/A
TTM Avg
3.77%
3Y Avg
-2.35%
5Y Avg
-2.90%
Market Cap
$816286.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-933.28%
5Y Avg
-622.19%
Market Cap
$845829.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$858810.00
Net Profit Margin
-16.50%
TTM Avg
-15.59%
3Y Avg
-166.33%
5Y Avg
-1668.08%
Market Cap
$859931.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$873967.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$381940.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $667373.00 | 6.30% | 4.12% | 0.00% | N/A |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | 3.77% | -2.35% | -2.90% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $816286.00 | 0.00% | 0.00% | -933.28% | -622.19% |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | -16.50% | -15.59% | -166.33% | -1668.08% |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
Operating Margin
0.0%
Net Profit Margin
6.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 9.14% |
| 2026-03-29 | 7.33% |
| 2025-12-31 | 0.00% |
| 2025-09-28 | 0.00% |
| 2025-06-29 | 0.00% |
| 2025-03-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-29 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
